NEXM · Insider Trading
NexMetals Mining Corp. Common Shares
Every open-market purchase and sale reported by NEXM officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2010-05-26 | Bassam Damaj | President and CEO | A | +1,500,000 | — |
| 2010-05-26 | Vivian H Liu | Executive Vice President | A | +1,302,631 | — |
| 2010-04-13 | Mark Westgate | Vice President & CFO | A | +150,000 | — |
| 2010-04-13 | Edward M. Cox | VP of Corp. Development | A | +75,000 | — |
| 2010-04-13 | Henry Jemil Esber | EVP Pre-Clinical Business Dev. | A | +100,000 | — |
| 2010-04-01 | Rusty Ray | Director | A | +32,680 | +$10.00K |
| 2010-04-01 | Richard J Berman | Director | A | +32,680 | +$10.00K |
| 2010-04-01 | Roberto Crea | Director | A | +32,680 | +$10.00K |
| 2010-04-01 | Leonard A Oppenheim | Director | A | +32,680 | +$10.00K |
| 2010-03-17 | Edward M. Cox | VP of Corp. Development | A | +324,327 | +$54.49K |
| 2010-03-17 | Bassam Damaj | President and CEO | A | +4,237,405 | +$711.88K |
| 2010-03-17 | Roberto Crea | Director | A | +62,832 | +$10.56K |
| 2010-03-17 | Henry Jemil Esber | EVP Pre-Clinical Business Dev. | A | +2,180,657 | +$366.35K |
| 2010-03-11 | Richard J Berman | Director | Sell | −61,873 | −$30.94K |
| 2010-01-13 | Edward M. Cox | VP of Corp. Development | A | +52,819 | +$8.87K |
| 2010-01-13 | Bassam Damaj | Chief Executive Officer | A | +690,100 | +$115.94K |
| 2010-01-13 | Roberto Crea | Director | A | +10,233 | +$1.72K |
| 2010-01-13 | Henry Jemil Esber | EVP Pre-Clinical Business Dev. | A | +355,139 | +$59.66K |
| 2009-12-18 | Leonard A Oppenheim | Director | Sell | −150,707 | −$63.42K |
| 2009-10-19 | Richard J Berman | Director | A | +20,541 | +$30.20K |
| 2009-10-19 | Leonard A Oppenheim | Director | A | +10,708 | +$15.74K |
| 2009-10-19 | David S Tierney | Director | A | +10,708 | +$15.74K |
| 2009-10-19 | Martin R Wade III | Director | A | +10,708 | +$15.74K |
| 2009-10-19 | Arthur D Emil | Director | A | +10,708 | +$15.74K |
| 2009-08-31 | Hemanshu Pandya | — | Sell | −325,000 | −$67.12K |
| 2009-07-24 | Jacob May | — | Sell | −4,120,900 | −$885.22K |
| 2009-06-11 | Leonard A Oppenheim | Director | A | +10,708 | +$15.74K |
| 2009-06-11 | Richard J Berman | Director | A | +20,541 | +$30.20K |
| 2009-06-11 | Martin R Wade III | Director | A | +10,708 | +$15.74K |
| 2009-06-11 | David S Tierney | Director | A | +10,708 | +$15.74K |
| 2009-06-11 | Arthur D Emil | Director | A | +10,708 | +$15.74K |
| 2009-02-18 | Arthur D Emil | Director | A | +21,416 | +$31.48K |
| 2009-02-18 | David S Tierney | Director | A | +21,416 | +$31.48K |
| 2009-02-18 | Martin R Wade III | Director | A | +21,416 | +$31.48K |
| 2009-02-18 | Richard J Berman | Director | A | +41,079 | +$60.39K |
| 2009-02-18 | Leonard A Oppenheim | Director | A | +21,416 | +$31.48K |
| 2009-02-18 | Jacob May | — | Buy | +610,363 | +$89.08K |
| 2009-01-07 | Jacob May | — | Buy | +1,161,726 | +$138.39K |
| 2008-10-14 | Jacob May | — | Buy | +2,220,436 | +$1.16M |
| 2008-10-06 | Mark Westgate | Vice President and CFO | A | +500,000 | — |
| 2008-10-06 | Hemanshu Pandya | Vice President and COO | A | +500,000 | — |
| 2008-09-17 | Leonard A Oppenheim | Director | A | +11,364 | +$1.48K |
| 2008-09-17 | Arthur D Emil | Director | A | +11,364 | +$1.48K |
| 2008-09-17 | David S Tierney | Director | A | +11,364 | +$1.48K |
| 2008-09-17 | Richard J Berman | Director | A | +13,258 | +$1.72K |
| 2008-09-10 | Southpoint GP, LLC | 10%+ Owner | Buy | −38,178,300 | −$9.65M |
| 2008-08-14 | Leonard A Oppenheim | Director | A | +24,705 | +$36.32K |
| 2008-08-14 | Hemanshu Pandya | Vice President and COO | A | +100,000 | — |
| 2008-08-14 | Arthur D Emil | Director | A | +22,210 | +$32.65K |
| 2008-08-14 | David S Tierney | Director | A | +70,320 | +$103.37K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the NEXM quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.